Executive Chairman of Genomic Health Inc. (GHDX, Financial) Randal W Scott sells 20,000 shares of GHDX on 07/13/2010 at an average price of $12.81 a share.
Genomic Health Inc. has a market cap of $365 million; its shares were traded at around $12.68 with and P/S ratio of 2.5.
GHDX is in the portfolios of Chuck Royce of Royce& Associates, Jim Simons of Renaissance Technologies LLC.
Genomic Health Inc. has a market cap of $365 million; its shares were traded at around $12.68 with and P/S ratio of 2.5.
GHDX is in the portfolios of Chuck Royce of Royce& Associates, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 05/17/2010 at the average price of 15.78. Kimberly J Popovits owns at least 310,624 shares after this. The price of the stock has decreased by 19.65% since.
- Sell: President and CEO Kimberly J Popovits sold 20,000 shares of GHDX stock on 03/16/2010 at the average price of 19.45. Kimberly J Popovits owns at least 288,116 shares after this. The price of the stock has decreased by 34.81% since.
CFO Recent Trades:
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 05/12/2010 at the average price of 15.87. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has decreased by 20.1% since.
- Sell: COO & CFO G Bradley Cole sold 5,000 shares of GHDX stock on 04/12/2010 at the average price of 16.9. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has decreased by 24.97% since.
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 03/11/2010 at the average price of 19.39. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has decreased by 34.61% since.
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 02/11/2010 at the average price of 17.51. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has decreased by 27.58% since.
Directors and Officers Recent Trades:
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 132,070 shares of GHDX stock on 02/19/2010 at the average price of 17.05. Brothers Life Sciences C Baker owns at least 4,300,744 shares after this. The price of the stock has decreased by 25.63% since.
- Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 3,645 shares of GHDX stock on 02/19/2010 at the average price of 17.05. Capital (gp), Llc 14159 owns at least 116,689 shares after this. The price of the stock has decreased by 25.63% since.
- Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 9,437 shares of GHDX stock on 02/10/2010 at the average price of 17.01. Capital (gp), Llc 14159 owns at least 113,044 shares after this. The price of the stock has decreased by 25.46% since.
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 341,854 shares of GHDX stock on 02/10/2010 at the average price of 17.01. Brothers Life Sciences C Baker owns at least 4,168,674 shares after this. The price of the stock has decreased by 25.46% since.
- Sell: Chief Scientific Officer Joffre Baker sold 4,629 shares of GHDX stock on 07/07/2010 at the average price of 13.05. Joffre Baker owns at least 167,717 shares after this. The price of the stock has decreased by 2.84% since.
